EP3254681B1 - N-(5s,6s,9r)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5h-cyclohepta[b]pyridin-9-yl-4-(2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate salt - Google Patents

N-(5s,6s,9r)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5h-cyclohepta[b]pyridin-9-yl-4-(2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate salt Download PDF

Info

Publication number
EP3254681B1
EP3254681B1 EP17180587.2A EP17180587A EP3254681B1 EP 3254681 B1 EP3254681 B1 EP 3254681B1 EP 17180587 A EP17180587 A EP 17180587A EP 3254681 B1 EP3254681 B1 EP 3254681B1
Authority
EP
European Patent Office
Prior art keywords
compound
pharmaceutical composition
hemisulfate salt
composition according
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP17180587.2A
Other languages
German (de)
French (fr)
Other versions
EP3254681A1 (en
Inventor
Daniel Richard Roberts
Richard Raymond Schartman
Chenkou Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201261603598P priority Critical
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to EP13708603.9A priority patent/EP2820016B1/en
Priority to PCT/US2013/027648 priority patent/WO2013130402A1/en
Publication of EP3254681A1 publication Critical patent/EP3254681A1/en
Application granted granted Critical
Publication of EP3254681B1 publication Critical patent/EP3254681B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links